California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
How Silicon Valley Bank Sparked Global Financial Panic

How Silicon Valley Bank Sparked Global Financial Panic

While its C.E.O. extolled innovation and the future of tech, Silicon Valley Bank paid less attention to risk management and was caught flat-footed by economic change.